• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Miglustat-[d9]

General Information
Catalog: BLP-004762
CAS: 1883545-56-9
Molecular Formula: C10H12D9NO4
Molecular Weight: 228.34
Chemical Structure
Miglustat-[d9]
Description Miglustat-[d9] is the labelled analogue of Miglustat. Miglustat is an inhibitor of the ceramide-specific glycosyltransferase, which catalyzes the first step of glycosphingolipid biosynthesis and is currently approved for the oral treatment of type I Gaucher disease (GD1).
Synonyms Miglustat D9; N-Butyldeoxynojirimycin-d9
IUPAC Name (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(1,1,2,2,3,3,4,4,4-nonadeuteriobutyl)piperidine-3,4,5-triol
Related CAS 72599-27-0 (unlabelled) 1883545-57-0 (hydrochloride)
Canonical SMILES CCCCN1CC(C(C(C1CO)O)O)O
InChI InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1/i1D3,2D2,3D2,4D2
InChI Key UQRORFVVSGFNRO-VYNVFXNFSA-N
Purity 95%; ≥95% atom D
Solubility Soluble in DMSO
Appearance Off-white Powder
Storage Store at -20°C

Interested in our Service & Products?
Need detailed information?

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All Rights Reserved.
Inquiry Basket